Log in/ Sign up

Novo Nordisk and Eli Lilly lowered prices of their leading obesity drugs Wegovy and Mounjaro in China to strengthen their positions in a rapidly expanding market facing rising obesity rates

30/12 21:30
Bullish
Bearish

Trending News